Focus On Women's And Mens Health

Host: Matt Birnholz, MD In the past several years, endometrial ablation has become an increasingly utilized method for minimalizing heavy menstrual bleeding. What's more, this procedure has since been brought into the outpatient setting. But what do clinicians who are considering bringing this procedural practice into their offices need to know before moving forward? Joining Dr. Matt Birnholz to discuss the benefits and limitations of in-office endometrial ablation is Dr. Monte Swarup, Partner at New Horizons Women’s Care from the Arizona OB/GYN Affiliates, and Clinical Assistant Professor at Midwestern University in Phoenix, AZ.

Host: Michael Krychman, MD For years, women's sexual health matters have been relatively ignored in both clinical practice and the public eye despite consistently heavy media attention drawn towards men's sexual issues and associated therapeutic products. But there is recent evidence that the tide of public awareness is beginning to change, and that's women's sexual health is becoming more openly discussed across medical, public, and corporate entities. Joining Dr. Michael Krychman to qualify this new trend and examine ways to open communication about sexual health with women in clinical practice is Dr. Alyssa Dweck, assistant clinical professor of OB/GYN at the Mount Sanai School of Medicine and expert in women's sexual health and dysfunction.

Most women in the United States will develop fibroids at some point in their lives. But the range of issues experienced is very wide, from asymptomatic disease to debilitating illness. Joining Dr. Renee Matthews to examine the mysterious etiology and pathogenesis, quality of life impacts, and modern medical and surgical approaches to fibroids is Dr. Jessica Shepherd, Assistant Professor of Clinical Obstetrics and Gynecology and the Director of Minimally Invasive Gynecology at the University of Illinois College of Medicine in Chicago. Dr. Shepherd is also founder of Her Viewpoint, an online community empowering women about their health.

Host: Matt Birnholz, MD Placenta accreta, also known as invasive placentation, is on the rise in US labor and delivery wards. It’s also potentially deadly, and healthcare professionals need to know how to detect it quickly and manage it safely. Joining Dr. Matt Birnholz at Omnia Education’s Women’s Health Annual Visit in New York to discuss the types, risks, and therapeutic approaches for placenta accreta is Dr. Jordan Perlow, Director of Maternal Fetal Medicine at Banner Good Samaritan Medical Center in Phoenix, AZ, and Associate Clinical Professor of OB/GYN at the University of Arizona School of Medicine.

Host: Matt Birnholz, MD The "FDA Jury" is out on treatment for uterine fibroids, and it’s not favorable to the practice of laparoscopic power morcellation. That update, and more importantly an expert practitioner’s perspectives on the FDA's suggested recommendations, is the focus of this interview. Joining Dr. Matt Birnholz to discuss the current landscape in uterine fibroid treatments, and the changing perceptions on power morcellation procedures, is Dr. Michael Randell, practicing OB/GYN in the Department of Obstetrics and Gynecology at Northside Hospital in Atlanta, GA. Dr. Randell is a Diplomat of the American Board of Obstetrics and Gynecology and the National Board of Medical Examiners.

Host: Prathima Setty, MD Post-menopausal patients have many options and choices for hormone therapy. But what are the issues and increased risks, if any? What are the latest updates from recent hormone therapy clinical trials and how does this impact clinical practice? Host Dr. Prathima Setty welcomes Dr. JoAnn V. Pinkerton to discuss various hormone therapy options and the latest updates in this area of concern for our patients. Dr. Pinkerton is the Director for the Midlife Division and the Midlife Health Center, a nationally recognized multidisciplinary center for women's midlife health. She serves as a member of the Board of Trustees for the North American Menopause Society and the Board of Directors for the National Women's Health Resource Center. About NAMS The interview was conducted live at The North American Menopause Society (NAMS) 2014 meeting. Founded in 1989, NAMS is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlif

Host: Bruce Japsen Guest: Mark Frohlich, MD The cancer treatment Provenge, known as a "therapeutic vaccine," was approved by the Food and Drug Administration in April, 2010 as a novel way to attack prostate tumors. But this is more than the story of a new treatment. Host Bruce Japsen learns about the long path to FDA approval for this unique therapy that some see as a watershed development in oncology, from Dr. Mark Frohlich, senior vice president of clinical affairs and chief medical officer of Dendreon Corporation, the Seattle-based biotech company that manufactures Provenge.

Host: Maurice Pickard, MD Guest: Abraham Morgentaler, MD It is widely believed that testosterone therapy for men with low testosterone can lead to an increased risk of prostate cancer. Dr. Abraham Morgentaler, associate clinical professor of urology at Harvard Medical School and author of the book Testosterone for Life, recalls the fascinating story of how this idea of high testosterone levels increasing the risk of prostate cancer originated, and suggests that in fact, the opposite might be true. What evidence supports boosting testosterone levels in men with low levels of the hormone, and that this might not raise a man's risk of developing prostate cancer? Hosted by Dr. Maurice Pickard.

Host: Shira Johnson, MD Guest: Stephen Schwartz, PhD Approximately 8000 men are diagnosed every year with testicular cancer in the United States. A first-of-its-kind study looked at whether or not marijuana use increases the risk. Dr. Stephen Schwartz, one of the researchers on the study and professor of epidemiology at the University of Washington, discusses his findings with host Dr. Shira Johnson. The two discuss how the research was conducted, who took part, and what needs to be done in the future to find more definitive answers.

Guest: David Soper, MD Host: Lisa Mazzullo, MD The number of women being treated for sexually transmitted infections in the United States is growing at an alarming rate, especially among women between the ages of 19 and 24. One of the biggest obstacles in treating these infections is persuading primary physicians to screen at-risk patients. Dr. David Soper, director of the division of gynecology and general obstetrics at the Medical University of South Carolina, discusses with host Dr. Lisa Mazzullo the treatment options for women and their partners, screening strategies and new trends in treating this ever-growing problem for young women.

Host: Lauren Streicher, MD Guest: Michael Holick, PhD, MD It seems these days patients know more about the benefits of Vitamin D than their physicians. Doctors are soaking up the information and making sure their patients are taking the proper levels of Vitamin D. Dr. Michael Holick, professor of medicine, physiology and biophysics and director of the Bone Health Care Clinic and the Heliotherapy, Light, and Skin Research Center at Boston University Medical Center, joins host Dr. Lauren Streicher to discuss the proper dosage, risk factors, geographical factors and benefits of Vitamin D.

Guest: Judith Florendo Host: Lauren Streicher, MD Chronic pelvic pain, incontinence and dyspareunia prompt many women to seek the help of their gynecologist. What most women don't know is that the next step in their treatment may be a visit to a physical therapist, for pelvic floor physical therapy. Ms. Judith Florendo, the Midwest regional representative in the women's section of the American Physical Therapy Association, joins host Dr. Lauren Streicher to talk about this growing area of women's health. Ms. Florendo explains how therapists go about evaluating their patients for treatment and who can benefit from this type of therapy.

Guest: Aine Collier, EdD Host: Leslie P. Lundt, MD Rarely do we encounter an issue in medicine as divisive as contraception. Author Aine Collier from the University of Maryland discusses the history of birth control with host Dr. Leslie Lundt.

Guest: Jonathon Moreno, PhD Host: Maurice Pickard, MD Dr. Johnathan Moreno discusses the implantation of DNA from two parents into an egg that has its nucleus removed to prevent diseases caused by genetic variants in the cytoplasmic mitochondria. Who is the mother? Join host, Dr. Maurie Pickard for an interesting discussion.

Guest: Sherman Elias, MD Host: Bruce Japsen Medical care for women is not just about delivering babies, but providing medical care at one location for all stages of their lives. Dr. Sherman Elias of Northwestern University's obstetrics and gynecology department tells the Chicago Tribune's Bruce Japsen about the move by U.S. hospitals to care for women at each and every stage of their lives.

Guest: Dan Shapiro, PhD Host: Susan Dolan, RN, JD Dr. Dan Shapiro, Director of the Medical Humanities Program and Professor of Clinical Psychiatry at the University of Arizona in Tuscon, Arizona, discusses his book, Delivering Amelia: The Story of a Young Gifted Obstetrician's Mistake and the Psychologist Who Helped Her.

Host: Lauren Streicher, MD Guest: Marla Mendelson, MD Marfan Syndrome, an inherited connective tissue disorder, affects 1 in 10,000 to 1 in 20,000 individuals. Women with Marfan Syndrome have a wide range of abnormalities involving the lungs, skin, ocular, musculoskeletal and cardiovascular systems. Today we are joined by Dr. Marla A. Mendelson, an assistant professor of Medicine at Northwestern University’s Feinberg School of Medicine, and director of the Women’s Cardiology program of the Bluhm Cardiovascular Institute of Northwestern Memorial Hospital which has just opened a clinic devoted to the management of women with Marfan syndrome.